Statistics Korea. Annual report on the cause of death statistics 2016 [Internet]. Daejeon: Statistics Korea; 2017 [cited 2017 Sep 22].
Yun YH, Rhee YS, Nam SY, Chae YM, Heo DS, Lee SW, et al. Public attitudes toward dying with dignity and hospice. Palliative care. Korean J Hosp Palliat Care 2004; 7: 17-28.
Ministry of Health and Welfare, National Cancer Center. Hospice palliative care introduction for palliative team members [Internet]. Goyang: National Cancer Center; 2016 [cited 2017 Nov 22].
Chiu TY, Hu WY, Chen CY. Prevalence and severity of symptoms in terminal cancer patients: a study in Taiwan. Support Care Cancer 2000; 8: 311-3.
Claessens P, Menten J, Schotsmans P, Broeckaert B. Palliative sedation: a review of the research literature. J Pain Symptom Manage 2008; 36: 310-33.
de Graeff A, Dean M. Palliative sedation therapy in the last weeks of life: a literature review and recommendations for standards. J Palliat Med 2007;10: 67-85.
Maltoni M, Scarpi E, Rosati M, Derni S, Fabbri L, Martini F, et al. Palliative sedation in end-of-life care and survival: a systematic review. J Clin Oncol 2012; 30: 1378-83.
Leonard CE, Freeman CP, Newcomb CW, Bilker WB, Kimmel SE, Strom BL, et al. Antipsychotics and the risks of sudden cardiac death and all-cause death: cohort studies in medicaid and dually-eligible medicaid-medicare beneficiaries of five states. J Clin Exp Cardiolog 2013; Suppl 10: 1-9.
Gu X, Cheng W, Chen M, Liu M, Zhang Z. Palliative sedation for terminally ill cancer patients in a tertiary cancer center in Shanghai, China. BMC Palliat Care 2015; 14: 5.
Cherny NI, Radbruch L; Board of the European Association for Palliative Care. European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care. Palliat Med 2009; 23:581-93.
Morita T, Bito S, Kurihara Y, Uchitomi Y. Development of a clinical guideline for palliative sedation therapy using the Delphi method. J Palliat Med 2005;8: 716-29.
Verkerk M, van Wijlick E, Legemaate J, de Graeff A. A national guideline for palliative sedation in the Netherlands. J Pain Symptom Manage 2007; 34:666-70.
International Association for Hospice and Palliative Care. Essential medicines for palliative care for World Health Organization EML 2013, IAHPC application to WHO with evidence [Internet]. Houston: IAHPC [cited 2017 Nov 22].
Good PD, Ravenscroft PJ, Cavenagh J. Effects of opioids and sedatives on survival in an Australian inpatient palliative care population. Intern Med J 2005; 35: 512-7.
Kim JY, Min HG, Kang MK, Cho GC, Bae SY, Baik DW, et al. Use of palliative sedation for intractable symptoms in the hospice palliative care unit. Korean J Fam Pract 2014; 4: 137-42.
Chiu TY, Hu WY, Lue BH, Cheng SY, Chen CY. Sedation for refractory symptoms of terminal cancer patients in Taiwan. J Pain Symptom Manage 2001; 21: 467-72.
Morita T, Tsunoda J, Inoue S, Chihara S. Effects of high dose opioids and sedatives on survival in terminally ill cancer patients. J Pain Symptom Manage 2001; 21: 282-9.
Stone P, Phillips C, Spruyt O, Waight C. A comparison of the use of sedatives in a hospital support team and in a hospice. Palliat Med 1997; 11: 140-4.
Golčić M, Dobrila-Dintinjana R, Golčić G, Čubranić A. The impact of combined use of opioids, antipsychotics, and anxiolytics on survival in the hospice setting. J Pain Symptom Manage 2018; 55: 22-30.
Ahn MH, Yeom CH, Lee HR. The factual survey of using sedative agents in terminal cancer patients. J Korean Acad Fam Med 2002; 23: 521-6.
Cho HJ, Kim HK, Kim KK, Kim YI, Suh SY, Cho KH, et al. Delirium in the final weeks of terminally ill cancer patients. Korean J Fam Med 2009; 30:285-91.
Caraceni A, Nanni O, Maltoni M, Piva L, Indelli M, Arnoldi E, et al. Impact of delirium on the short term prognosis of advanced cancer patients. Italian Multicenter Study Group on Palliative Care. Cancer 2000; 89: 1145-9.
Toscani P, Brunelli C, Miccinesi G, Costantini M, Gallucci M, Tamburini M, et al. Predicting survival in terminal cancer patients: clinical observation or quality-of-life evaluation? Palliat Med 2005; 19: 220-7.
Jang JE, Kim SW, Kim YH, Kim SY, Kim JM, Shin IS, et al. Relationship between severity of delirium and mortality in patients with cancer. J Korean Soc Biol Ther Psychiatry 2011; 17: 131-9.
Radha Krishna LK, Poulose VJ, Goh C. The use of midazolam and haloperidol in cancer patients at the end of life. Singapore Med J 2012; 53: 62-6.